Thanks to our RISW supporting sponsors: Argenx; Astellas; BlankBio; CIMS; Clindata; DuBu Research; HopeAI; Innovatio Statistics; Neurocrine Biosciences; NouStarX; Otsuka; Penfield; Phase V; Phastar; Quantive Intelligence; Regeneron; Servier; Stata; The Lotus Group; VeraMed; & Vertex.
September 18, 2026 at 10:18 PM
Thanks to our RISW supporting sponsors: Argenx; Astellas; BlankBio; CIMS; Clindata; DuBu Research; HopeAI; Innovatio Statistics; Neurocrine Biosciences; NouStarX; Otsuka; Penfield; Phase V; Phastar; Quantive Intelligence; Regeneron; Servier; Stata; The Lotus Group; VeraMed; & Vertex.
Thanks to our #RISW2026 supporting sponsors: Argenx; Astellas; BlankBio; CIMS; Clindata; DuBu Research; HopeAI; Innovatio Statistics; Neurocrine Biosciences; NouStarX; Otsuka; Penfield; Phase V; Phastar; Quantive Intelligence; Regeneron; Servier; Stata; The Lotus Group; VeraMed; & Vertex. #STATSSKY
September 17, 2026 at 7:57 PM
Thanks to our RISW supporting sponsors: Argenx; Astellas; BlankBio; CIMS; Clindata; DuBu Research; HopeAI; Innovatio Statistics; Neurocrine Biosciences; NouStarX; Otsuka; Penfield; Phase V; Phastar; Quantive Intelligence; Regeneron; Servier; Stata; The Lotus Group; VeraMed; & Vertex.
September 16, 2026 at 4:50 PM
Thanks to our RISW supporting sponsors: Argenx; Astellas; BlankBio; CIMS; Clindata; DuBu Research; HopeAI; Innovatio Statistics; Neurocrine Biosciences; NouStarX; Otsuka; Penfield; Phase V; Phastar; Quantive Intelligence; Regeneron; Servier; Stata; The Lotus Group; VeraMed; & Vertex.
I have to do 2x the work I did last year & I simply couldn't do it without AI.
There's things I still hopeAI will eventually help w/ but what it does today is more than helpful: It's NECESSARY.
The Copilot chat app is always open on my desktop to answer questions as a critical part of my workday.
There's things I still hopeAI will eventually help w/ but what it does today is more than helpful: It's NECESSARY.
The Copilot chat app is always open on my desktop to answer questions as a critical part of my workday.
August 17, 2025 at 4:50 PM
I have to do 2x the work I did last year & I simply couldn't do it without AI.
There's things I still hopeAI will eventually help w/ but what it does today is more than helpful: It's NECESSARY.
The Copilot chat app is always open on my desktop to answer questions as a critical part of my workday.
There's things I still hopeAI will eventually help w/ but what it does today is more than helpful: It's NECESSARY.
The Copilot chat app is always open on my desktop to answer questions as a critical part of my workday.
HopeAI Revolutionizes Cancer Drug Trials Using AI-Generated Synthetic Data at ASCO 2025#United_States#New_York#Cancer_Trials#ASCO_2025#HopeAI
HopeAI Revolutionizes Cancer Drug Trials Using AI-Generated Synthetic Data at ASCO 2025
HopeAI showcases its innovative application of AI-generated synthetic data to enhance the efficiency of cancer drug trials at ASCO 2025.
third-news.com
August 13, 2025 at 6:11 PM
HopeAI Revolutionizes Cancer Drug Trials Using AI-Generated Synthetic Data at ASCO 2025#United_States#New_York#Cancer_Trials#ASCO_2025#HopeAI
Transforming Drug Development: HopeAI and Mayo Clinic's Revolutionary Partnership#USA#New_York#Mayo_Clinic#AI_Drug_Development#HopeAI
Transforming Drug Development: HopeAI and Mayo Clinic's Revolutionary Partnership
HopeAI has officially joined the Mayo Clinic Platform to enhance drug development using AI, enabling innovative clinical trial designs and improving patient outcomes.
third-news.com
August 13, 2025 at 4:04 AM
Transforming Drug Development: HopeAI and Mayo Clinic's Revolutionary Partnership#USA#New_York#Mayo_Clinic#AI_Drug_Development#HopeAI
#VSA VSA Signs Letter of Intent to Acquire HopeAI, Accelerating Expansion into AI in Life Science
https://www.stocktitan.net/news/VSA/vsa-signs-letter-of-intent-to-acquire-hope-ai-accelerating-expansion-yxp2ljl04023.html
https://www.stocktitan.net/news/VSA/vsa-signs-letter-of-intent-to-acquire-hope-ai-accelerating-expansion-yxp2ljl04023.html
VSA Signs Letter of Intent to Acquire HopeAI, Accelerating Expansion into AI in Life Science
VSA (NASDAQ: VSA) has signed a non-binding letter of intent to acquire HopeAI Inc., an AI company specializing in clinical development optimization. The acquisition will be executed through an exchange of VSA's restricted Class A ordinary shares, with the exact amount to be determined based on HopeAI's valuation. Founded in 2023, HopeAI leverages AI technology to address key challenges in pharmaceutical clinical trials through its PURE Evidence, SynthIPD, and CARA Design platforms. The company has demonstrated significant results, including reducing clinical timelines by up to 2.5 years, decreasing Phase 3 trial sample sizes by 20%, and enabling 24-hour FDA feedback response times. With pharmaceutical companies spending over $200 billion on clinical development in 2024 and average development cycles lasting 9 years, this strategic acquisition aims to enhance VSA's position in the AI biopharmaceutical sector.
www.stocktitan.net
June 17, 2025 at 8:30 AM
#VSA VSA Signs Letter of Intent to Acquire HopeAI, Accelerating Expansion into AI in Life Science
https://www.stocktitan.net/news/VSA/vsa-signs-letter-of-intent-to-acquire-hope-ai-accelerating-expansion-yxp2ljl04023.html
https://www.stocktitan.net/news/VSA/vsa-signs-letter-of-intent-to-acquire-hope-ai-accelerating-expansion-yxp2ljl04023.html
HopeAI schließt Partnerschaft mit Mayo Clinic Platform zur Revolutionierung der Arzneimittelentwicklung durch KI
HopeAI, ein führendes Unternehmen im Bereich künstliche Intelligenz (KI) zur Beschleunigung der Arzneimittelentwicklung, ist dem renommierten Mayo Clinic Platform Accelerate Programm…
HopeAI, ein führendes Unternehmen im Bereich künstliche Intelligenz (KI) zur Beschleunigung der Arzneimittelentwicklung, ist dem renommierten Mayo Clinic Platform Accelerate Programm…
HopeAI schließt Partnerschaft mit Mayo Clinic Platform zur Revolutionierung der Arzneimittelentwicklung durch KI
HopeAI, ein führendes Unternehmen im Bereich künstliche Intelligenz (KI) zur Beschleunigung der Arzneimittelentwicklung, ist dem renommierten Mayo Clinic Platform Accelerate Programm beigetreten. Diese Zusammenarbeit verschafft HopeAI Zugang zur weltweit führenden Plattform für reale medizinische Daten (Real-World Data, RWD) der Mayo Clinic, um klinische Studien schneller, präziser und zuverlässiger zu gestalten. Die Entwicklung neuer Medikamente ist eine der größten Herausforderungen im modernen Gesundheitswesen.
lab-news.de
August 13, 2025 at 5:11 AM
HopeAI schließt Partnerschaft mit Mayo Clinic Platform zur Revolutionierung der Arzneimittelentwicklung durch KI
HopeAI, ein führendes Unternehmen im Bereich künstliche Intelligenz (KI) zur Beschleunigung der Arzneimittelentwicklung, ist dem renommierten Mayo Clinic Platform Accelerate Programm…
HopeAI, ein führendes Unternehmen im Bereich künstliche Intelligenz (KI) zur Beschleunigung der Arzneimittelentwicklung, ist dem renommierten Mayo Clinic Platform Accelerate Programm…
Thoughts on this? >> HopeAI Joins Mayo Clinic Platform to Transform the Future of
Drug Development with AI >> Comment below! #healthtech #IoT #mhealth #AI #industry40
Drug Development with AI >> Comment below! #healthtech #IoT #mhealth #AI #industry40
HopeAI Joins Mayo Clinic Platform to Transform the Future of
Drug Development with AI
NEW YORK, Aug. 12, 2025 /PRNewswire/ — HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined the prestigious Mayo Clinic Platform Accelerate program. This partnership grants HopeAI access to Mayo Clinic’s world-class real-world data (RWD) platform, enabling faster, smarter, and more confident clinical trial design. Bringing a …
dlvr.it
August 13, 2025 at 4:17 AM
Thoughts on this? >> HopeAI Joins Mayo Clinic Platform to Transform the Future of
Drug Development with AI >> Comment below! #healthtech #IoT #mhealth #AI #industry40
Drug Development with AI >> Comment below! #healthtech #IoT #mhealth #AI #industry40
HopeAI links up with Mayo Clinic to cut time and cost of drug trials with AI firstwordpharma.com/story/5989115
August 14, 2025 at 2:55 AM
HopeAI links up with Mayo Clinic to cut time and cost of drug trials with AI firstwordpharma.com/story/5989115